Senators challenged Kennedy, who was nominated as health secretary by President Trump, on his long track record of ...

States and providers regained access to a key healthcare payments portal late Tuesday amid pushback over the Trump ...

The approval adds a new indication for GLP-1 drugs and gives Novo an advantage over Lilly’s rival diabetes drug Mounjaro, ...

BioAge scrapped the drug at the center of its $198 million initial public offering last year. Elsewhere, Akero and 89bio ...

The expansion is a natural progression for Upperton who already develops and manufactures small molecule and biological, ...

Federal agencies must stop disbursing financial assistance under a new budget directive, threatening funding for providers ...

ITM's lutetium-containing therapy extended progression-free survival versus everolimus in patients with a specific kind of ...

The clearance is a step forward in AstraZeneca and Daiichi Sankyo’s plan to position antibody-drug conjugates like Enhertu ...

Multi-Modal Models: A multi-modal discovery approach was implemented that engineered-in potency against the novel target and engineered-out a specific off-target interaction. The NCE library displayed ...

Sapio Sciences, the science-awareTM lab informatics platform, today announced that Schrödinger, a global leader in computational chemistry, has adopted the Sapio Platform to improve data management, ...

Helicore, which is developing a GIP-blocking antibody, is the fourth obesity drug developer to receive funding from Versant ...

The startup says its specially constructed RNAi therapies can get deep into brain tissue, yielding new ways to treat neurological conditions like Huntington’s.